PTGS2 and rheumatoid arthritis: Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, approved in more than 80 countries worldwide and indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.